IDHIFA Trademark

Trademark Overview

On Wednesday, May 4, 2016, a trademark application was filed for IDHIFA with the United States Patent and Trademark Office. The USPTO has given the IDHIFA trademark a serial number of 87024412. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, December 22, 2023. This trademark is owned by Celgene Corporation. The IDHIFA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of leukemia, other cancers, and auto-immune diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
idhifa

General Information

Serial Number87024412
Word MarkIDHIFA
Filing DateWednesday, May 4, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, December 22, 2023
Registration Number5244018
Registration DateTuesday, July 18, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of leukemia, other cancers, and auto-immune diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "IDHIFA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 22, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, December 22, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 22, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 27, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 18, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 25, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2017ASSIGNED TO LIE
Monday, March 6, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 21, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, August 17, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 17, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, August 17, 2016SUSPENSION LETTER WRITTEN
Tuesday, August 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 12, 2016ASSIGNED TO LIE
Tuesday, August 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 1, 2016NON-FINAL ACTION E-MAILED
Monday, August 1, 2016NON-FINAL ACTION WRITTEN
Friday, July 22, 2016ASSIGNED TO EXAMINER
Monday, May 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 7, 2016NEW APPLICATION ENTERED

Related Keywords

idhifa preparations pharmaceutical immune inhibitory cytokine drugs modulate system namely diseases